EGFR may couple moderate alcohol consumption to increased breast cancer risk

Código QR

EGFR may couple moderate alcohol consumption to increased breast cancer risk

Christopher P Mill1, Julia A Chester2, David J Riese II11Purdue University School of Pharmacy, Purdue University Center for Cancer Research, 2Purdue University Department of Psychological Sciences, West Lafayette, IN, USAAbstract: Alcohol consumption is an established risk factor for breast cancer....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Christopher P Mill, Julia A Chester, David J Riese II
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/b490206e9dfa422583462a98071e66b9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
por: Nina Radosevic-Robin, et al.
Publicado: (2021)

Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity
por: Takahiro Yoshizawa, et al.
Publicado: (2021)

Adolescent alcohol, nuts, and fiber: combined effects on benign breast disease risk in young women
por: Catherine S. Berkey, et al.
Publicado: (2020)

Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
por: Suda K, et al.
Publicado: (2013)

Hypofractionated radiotherapy after conservative surgery may increase low–intermediate grade late fibrosis in breast cancer patients
por: Digesù C, et al.
Publicado: (2018)

PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
por: Min Li, et al.
Publicado: (2021)

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
por: Katherine D. Crew, et al.
Publicado: (2017)

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
por: Barbara Melosky, et al.
Publicado: (2021)

Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
por: Karachaliou N, et al.
Publicado: (2014)

Analysis of Increased EGFR and IGF-1R Signaling and Its Correlation with Socio-Epidemiological Features and Biological Profile in Breast Cancer Patients: A Study in Northern Brazil
por: Silva Rocha F, et al.
Publicado: (2021)

The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008
por: Alghamdi IG, et al.
Publicado: (2013)

Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells
por: Mikkel G. Terp, et al.
Publicado: (2021)

A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer
por: Natalia J. Gurule, et al.
Publicado: (2021)

The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients
por: Sunao Tanaka, et al.
Publicado: (2017)

Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient
por: Maurício Fernando Silva Almeida Ribeiro, et al.
Publicado: (2021)

Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance
por: Chenyue Dai MM, et al.
Publicado: (2021)

Correction: Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Publicado: (2021)

Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT)
por: Alfredo Addeo, et al.
Publicado: (2021)

EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?
por: Wang QS, et al.
Publicado: (2013)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou P, et al.
Publicado: (2015)

Dormancy in breast cancer
por: Banys M, et al.
Publicado: (2012)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Nehmat Houssami
Publicado: (2021)

Breast cancer in Mongolia: an increasingly important health policy issue
por: Demchig D, et al.
Publicado: (2017)

Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
por: Xiaoying Zhang
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Thomas P. Slavin, et al.
Publicado: (2017)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
por: Allan Lipton
Publicado: (2011)

Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis
por: Sixten Harborg, et al.
Publicado: (2021)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Sasha E. Stanton, et al.
Publicado: (2021)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Mathilde M. M. Almekinders, et al.
Publicado: (2021)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Francisco Beca, et al.
Publicado: (2021)

A DNA methylation-based liquid biopsy for triple-negative breast cancer
por: Katrina Cristall, et al.
Publicado: (2021)

An alternative model for (breast) cancer predisposition
por: Erik Teugels, et al.
Publicado: (2017)

Current strategies for the prevention of breast cancer
por: Advani P, et al.
Publicado: (2014)

Optical imaging for breast cancer prescreening
por: Godavarty A, et al.
Publicado: (2015)

Breast carcinomas: variations in sonoelastographic appearance
por: Fleury E, et al.
Publicado: (2014)

Breast reconstruction: current and future options
por: Paul Jr H, et al.
Publicado: (2011)

Mammographic texture features associated with contralateral breast cancer in the WECARE Study
por: Gordon P. Watt, et al.
Publicado: (2021)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
por: Marion Maetens, et al.
Publicado: (2017)